Metronomic maintenance therapy in refractory acute myeloblastic leukemia with monosomy 7

Shahriari, M. and Abdolkarimi, B. and Saleh, F. and Salajeghe, P. (2015) Metronomic maintenance therapy in refractory acute myeloblastic leukemia with monosomy 7. Iranian Journal of Blood and Cancer, 7 (5). pp. 231-234.

Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

Patients with acute myeloblastic leukemia (AML) with monosomy 7 are a group of patients with refractory AML who have a very poor prognosis. Therefore, rationally designed new therapies, including metronomic chemotherapy regimen with histidine deacetylase inhibitors (Valporic acid, ATRA) are being investigated as potential treatments for the population of refractory cases of AML. Herein, we report a patient with primary refractory AML who was treated with oral low-dose chemotherapy after standard systemic chemotherapy. © 2015, Iranian Pediatric Hematology and Oncology Society. All rights reserved.

Item Type: Article
Additional Information: cited By 0
Depositing User: eprints admin
Date Deposited: 02 Jul 2018 08:45
Last Modified: 02 Jul 2018 08:45
URI: http://eprints.iums.ac.ir/id/eprint/4618

Actions (login required)

View Item View Item
Iran University of Medical Sciences Scientific Repository is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.